We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Mylan Will Sell 2 Generics Over Meda Purchase in FTC Settlement
Mylan Will Sell 2 Generics Over Meda Purchase in FTC Settlement
Mylan has agreed to shed two generics that treat muscle pain and epilepsy to allay FTC antitrust concerns, clearing the way for its $7.2 billion acquisition of Meda.